Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy

M Klingebiel; C Arsov; T Ullrich; M Quentin; R Al-Monajjed; D Mally; LM Sawicki; A Hiester; I Esposito; P Albers; G Antoch; L Schimmöller

Data in Brief (Dec 2022)

Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy

M Klingebiel,
C Arsov,
T Ullrich,
M Quentin,
R Al-Monajjed,
D Mally,
LM Sawicki,
A Hiester,
I Esposito,
P Albers,
G Antoch,
L Schimmöller

Affiliations

M Klingebiel: University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany
C Arsov: University Dusseldorf, Medical Faculty, Department of Urology, D-40225 Dusseldorf, Germany
T Ullrich: University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany
M Quentin: University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany
R Al-Monajjed: University Dusseldorf, Medical Faculty, Department of Urology, D-40225 Dusseldorf, Germany
D Mally: University Dusseldorf, Medical Faculty, Department of Urology, D-40225 Dusseldorf, Germany
LM Sawicki: University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany
A Hiester: University Dusseldorf, Medical Faculty, Department of Urology, D-40225 Dusseldorf, Germany
I Esposito: University Dusseldorf, Medical Faculty, Department of Pathology, D-40225 Dusseldorf, Germany
P Albers: University Dusseldorf, Medical Faculty, Department of Urology, D-40225 Dusseldorf, Germany
G Antoch: University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany
L Schimmöller: University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany; Corresponding author at: University Dusseldorf, Medical Faculty Duesseldorf, Germany.

Journal volume & issue: Vol. 45
p. 108683

Abstract

Read online

This is a data article from the original publication “Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy” [1]. From January 2014 to April 2019 a sample collective of 785 patients with 3T multiparametric magnetic resonance imaging (mp-MRI) of the prostate and subsequent combined systematic biopsy (SB) and magnetic resonance imaging/ultrasound (US) fusion-guided biopsy (TB) was retrospectively analyzed. Prostate cancer (PCa) detection by TB and/or additional SB was analyzed.

Published in Data in Brief

ISSN: 2352-3409 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Medicine (General): Computer applications to medicine. Medical informatics; Science: Science (General)
Website: http://www.journals.elsevier.com/data-in-brief/

About the journal

Abstract

Keywords